Table 1.
Patient demographics and clinical parameters
| pGSH3-β | |||
|---|---|---|---|
| (negative = <0.6) Total cases = 27 n (%) | (postive = ≥ 0.6) total cases = 56 n (%) | Total cases = 83 | |
| Age [n (mean)] | 27 (63.3) | 56(65.5) | 83 |
| Gender | |||
| Female | 5(18.5) | 9(16.1) | 14 |
| Male | 22(81.5) | 47(83.9) | 69 |
| Stage | |||
| I-II | 4(14.8) | 4(7.1) | 8 |
| III | 6(22.2) | 14(25.0) | 20 |
| IV | 15 (55.6) | 37(56.1) | 52 |
| Missing | 2(7.4) | 1(1.8) | 3 |
| B Symptoms | |||
| Yes | 8(29.6) | 15(26.8) | 23 |
| No | 17(63.0) | 39(69.6) | 56 |
| Missing | 2(7.4) | 2(3.6) | 4 |
| GI Involvement | |||
| Yes | 6(22.2) | 6(10.7) | 12 |
| No | 19(70.4) | 48(85.7) | 67 |
| Missing | 2(7.4) | 2(3.6) | 4 |
| IPI | |||
| 0-2 | 15(55.6) | 36(64.3) | 51 |
| ≥3 | 4(14.8) | 12(21.4) | 16 |
| missing | 8 (29.6) | 8(14.3) | 16 |
| β-catenin | |||
| 0-1 | 23(85.2) | 27(48.2) | 50 |
| 2-3 | 3(70.4) | 23(41.1) | 26 |
| Missing | 1(3.7) | 6(10.7) | 7 |
| Cyclin D1 | |||
| 1-2 | 18(66.7) | 23(41.1) | 41 |
| 3 | 3(11.1) | 26(46.4) | 29 |
| Missing | 6(22.2) | 7(12.5) | 13 |
| KI67 | |||
| 0-3 | 21(77.8) | 37(66.1) | 58 |
| 4 | 4(14.8) | 18(32.1) | 22 |
| Missing | 2(7.4) | 1(1.8) | 3 |